US Broker Ratings

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a Potential 224% Upside in Biotech Innovation

Candel Therapeutics, Inc. (CADL), a burgeoning player in the biotechnology sector, is capturing attention with its promising pipeline of cancer immunotherapies. Headquartered in Needham, Massachusetts, Candel..

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector

Anbio Biotechnology (NNNN), a relatively young player in the healthcare sector, operates out of Frankfurt am Main, Germany, and focuses on providing innovative in vitro diagnostics..

Aura Biosciences, Inc. (AURA): Investor Outlook with a Remarkable 257.93% Potential Upside

Aura Biosciences, Inc. (AURA) is garnering significant attention in the investment community, thanks to its promising pipeline and a staggering potential upside of 257.93%. As a..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Unveiling a Potential 546% Upside in the Biotech Sector

In the ever-evolving landscape of biotechnology, aTyr Pharma, Inc. (NASDAQ: ATYR) is carving out a niche with its innovative approach to tackling fibrosis and inflammation. With..

Investor Outlook: Aurora Cannabis Inc. (ACB) Poised for 48.97% Upside in a Flourishing Sector

Aurora Cannabis Inc. (NASDAQ: ACB), a prominent player in the healthcare sector specifically within the drug manufacturing niche, continues to captivate investor interest despite the challenges..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Niche in Veterinary Vaccines Amidst Market Challenges

Individual investors eyeing opportunities in the healthcare sector might find Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT) a curious case. Operating in the drug manufacturing industry, Zhengye..

UroGen Pharma Ltd. (URGN) Stock Analysis: Strong Buy Ratings and a 65% Potential Upside

In the ever-evolving biotechnology sector, UroGen Pharma Ltd. (NASDAQ: URGN) stands out as a promising contender with its innovative approach to urothelial and specialty cancers. With..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring the 86.81% Potential Upside in Women’s Cancer Therapies

Investors seeking opportunities within the biopharmaceutical sector may want to turn their attention to Olema Pharmaceuticals, Inc. (NASDAQ: OLMA). The company, headquartered in San Francisco, California,..

Absci Corporation (ABSI) Stock Analysis: Exploring the 173.66% Potential Upside in Biotech AI Innovations

Absci Corporation (NASDAQ: ABSI) is capturing investor attention with its ambitious use of artificial intelligence (AI) in drug creation, a move that positions it uniquely within..

Erasca, Inc. (ERAS) Stock Analysis: An Investor’s Look at the 0.91% Potential Upside

Erasca, Inc. (NASDAQ: ERAS), a burgeoning player in the biotechnology sector, is catching investor attention with its focus on precision oncology therapies targeting RAS/MAPK pathway-driven cancers...

Wave Life Sciences Ltd. (WVE) Growth Potential: Analysts Predict 141% Upside

Wave Life Sciences Ltd. (NASDAQ: WVE) is capturing the attention of investors with a robust growth outlook and significant upside potential. Operating in the biotechnology sector,..

Evolent Health, Inc. (EVH) Stock Analysis: Navigating a 147% Potential Upside Amidst Healthcare Challenges

Evolent Health, Inc. (NYSE: EVH), a prominent player in the healthcare sector, operates within the health information services industry. Headquartered in Arlington, Virginia, Evolent focuses on..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 53% Upside Potential

Pulse Biosciences, Inc (NASDAQ: PLSE) stands as an intriguing prospect for investors looking to capitalize on innovative breakthroughs in the healthcare sector. As a novel bioelectric..

Integra LifeSciences Holdings Corp (IART) Investor Outlook: Analyzing a 34% Potential Upside in the Medical Devices Sector

Investors looking to explore opportunities within the medical devices sector might find Integra LifeSciences Holdings Corp (IART) an intriguing proposition. As a player in the healthcare..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 173.72% Potential Upside in the Healthcare Sector

Investors with a keen interest in the healthcare sector may find Opko Health, Inc. (NASDAQ: OPK) an intriguing option, especially given its substantial potential upside of..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Unpacking a 59% Upside Potential

Vera Therapeutics, Inc. (NASDAQ: VERA) stands out in the biotechnology sector, drawing considerable attention from investors seeking growth in the healthcare industry. Despite its current challenges,..

agilon health, inc. (AGL) Stock Analysis: Navigating a Challenging Healthcare Landscape with a 3.89% Potential Upside

agilon health, inc. (NYSE: AGL) operates within the healthcare sector, focusing on medical care facilities for seniors through its innovative platform. Based in Westerville, Ohio, the..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Evaluating a 13.30% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, has been drawing attention with its focus on therapies for autoimmune diseases. With a..

Evotec SE (EVO) Stock Analysis: A Healthcare Innovator with a 55% Potential Upside

Evotec SE (EVO), a notable player on the healthcare scene, is drawing significant attention from investors, not least due to an intriguing potential upside of 55.27%...

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 35.71% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, has been capturing investor attention with its robust revenue growth and potential price upside...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds